1. |
Lu CY, Xia JF, Wang B, et al. Advances in diagnosis, treatments, and molecular mechanistic studies of traumatic brain injury. Biosci Trends, 2015, 9(3): 138-148.
|
2. |
胡迎春, 陈睦虎, 钟武, 等. 大鼠颅脑损伤早期与晚期相关基因生物信息学分析. 医学信息, 2013, 26(18): 269-269, 270.
|
3. |
官明, 陈礼刚, 董劲虎, 等. 半胱氨酸蛋白酶-3 抑制剂 z-DEVD-fmk 对大鼠脑创伤后神经细胞凋亡及血浆血管内皮素、降钙素基因相关肽水平的影响. 临床神经病学杂志, 2014, 27(3): 207-209.
|
4. |
Mukherjee D, Sarmiento JM, Patil CG. Intracranial-pressure monitoring in traumatic brain injury. N Engl J Med, 2013, 368(18): 1748-1749.
|
5. |
Li W, Wang C, Peng J, et al. Naringin inhibits TNF-a induced oxidative stress and inflammatory response in HUVECs via Nox4/NF-κ B and PI3K/Akt pathways. Curr Pharm Biotechnol, 2014, 15(12): 1173-1182.
|
6. |
Zhao J, Xu YM, Zong YJ, et al. Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells. Hematology, 2011, 16(4): 232-235.
|
7. |
Cheng ZG, Zhang GD, Shi PQ, et al. Expression and antioxidation of Nrf2/ARE pathway in traumatic brain injury. Asian Pac J Trop Med, 2013, 6(4): 305-310.
|
8. |
Wu XM, Mao H, Liu J, et al. Dynamic change of SGK expression and its role in neuron apoptosis after traumatic brain injury. Int J Clin Exp Pathol, 2013, 6(7): 1282-1293.
|
9. |
Zhang L, Yan R, Zhang Q, et al. Survivin, a key component of the Wnt/β-catenin signaling pathway, contributes to traumatic brain injury-induced adult neurogenesis in the mouse dentate gyrus. Int J Mol Med, 2013, 32(4): 867-875.
|
10. |
Wierzbicki PM, Rybarczyk A. The hippo pathway in colorectal cancer. Folia Histochem Cytobiol, 2015, 53(2): 105-119.
|
11. |
Maugeri-Saccà M, Barba M, Pizzuti LA, et al. The hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications. Expert Rev Mol Med, 2015, 17: e14.
|
12. |
Kang W, Cheng AS, Yu J, et al. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers. World J Gastroenterol, 2016, 22(3): 1279-1288.
|
13. |
Harvey KF, Zhang X, Thomas DM. The hippo pathway and human cancer. Nat Rev Cancer, 2013, 13(4): 246-257.
|
14. |
Schlegelmilch K, Mohseni M, Kirak O, et al. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell, 2011, 144(5): 782-795.
|
15. |
胡迎春, 钟武, 陈睦虎, 等. 基于生物信息学探讨Yes-相关蛋白在大鼠心肌缺血再灌注损伤中的表达. 华西医学, 2016, 31(6): 1008-1012.
|
16. |
Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov, 2014, 13(1): 63-79.
|
17. |
Li N, Lim G, Chen L, et al. Spinal expression of Hippo signaling components YAP and TAZ following peripheral nerve injury in rats. Brain Res, 2013, 1535: 137-147.
|
18. |
Orcholski ME, Zhang Q, Bredesen DE. Signaling via amyloid precursor-like proteins APLP1 and APLP2. J Alzheimers Dis, 2011, 23(4): 689-699.
|
19. |
Heallen T, Zhang M, Wang J, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science, 2011, 332(628): 458-461.
|
20. |
Xin M, Kim Y, Sutherland LB, et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci USA, 2013, 110(34): 13839-13844.
|
21. |
Zhou Q, Li L, Zhao B, et al. The hippo pathway in heart development, regeneration, and diseases. Circ Res, 2015, 116(8): 1431-1447.
|